Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
jueves, 6 de agosto de 2020
No benefit of plasma therapy in reducing COVID-19 mortality risk, says AIIMS trial interim analysis | India News,The Indian Express
No benefit of plasma therapy in reducing COVID-19 mortality risk, says AIIMS trial interim analysis
The therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus infected patient to help kickstart the immune system to fight back the infection.
No hay comentarios:
Publicar un comentario